Thus, this retrospective, multicentre study aimed to evaluate the dynamic evolution of DEK-NUP214 transcripts before and after allo-HSCT as well as the impact of pretransplant DEK-NUP214 status on posttransplant outcomes in AML patients. This evidence concerns the gene NUP214 and acute myeloid leukemia.